CG
Clinton Group Portfolio holdings
AUM
$279M
1-Year Return
4.7%
This Quarter Return
-2.8%
1 Year Return
+4.7%
3 Year Return
+10.04%
5 Year Return
-9.24%
10 Year Return
–
AUM
$932M
AUM Growth
-$180M
(-16%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-19.21%
Top 10 Holdings %
Top 10 Hldgs %
19.74%
Holding
556
New
182
Increased
73
Reduced
95
Closed
205
Top Buys
| 1 |
Avery Dennison
AVY
|
$14.7M |
| 2 |
AbbVie
ABBV
|
$13.4M |
| 3 |
Dominion Energy
D
|
$12.2M |
| 4 |
Darden Restaurants
DRI
|
$11.9M |
| 5 |
Meta Platforms (Facebook)
META
|
$11.8M |
Top Sells
| 1 |
PPL Corp
PPL
|
$12.8M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
$9.68M |
| 3 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
$8.89M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
$8.66M |
| 5 |
Tyson Foods
TSN
|
$8.54M |
Sector Composition
| 1 | Financials | 13.11% |
| 2 | Technology | 13% |
| 3 | Materials | 12.22% |
| 4 | Healthcare | 11.97% |
| 5 | Consumer Discretionary | 11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Hubbell
HUBB
$23.1B
| $327K | 0.04% |
+2,688
| New | +$327K |
|
|
ALXN
302
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $322K | 0.03% |
+2,891
| New | +$322K |
|
303
KKR & Co
KKR
$123B
| $320K | 0.03% |
+15,746
| New | +$320K |
|
|
IBKC
304
DELISTED
IBERIABANK Corp
IBKC
| $317K | 0.03% |
4,059
-426
| -9% | -$33.3K |
|
305
Salesforce
CRM
$233B
| $316K | 0.03% |
2,716
-15,180
| -85% | -$1.77M |
|
306
Factset
FDS
$13.9B
| $311K | 0.03% |
1,558
+9
| +0.6% | +$1.8K |
|
|
APU
307
DELISTED
AmeriGas Partners, L.P.
APU
| $306K | 0.03% |
+7,664
| New | +$306K |
|
308
MDU Resources
MDU
$3.31B
| $293K | 0.03% |
27,403
-46,260
| -63% | -$495K |
|
309
EQT Corp
EQT
$32.3B
| $291K | 0.03% |
+11,264
| New | +$291K |
|
310
Atlassian
TEAM
$43.8B
| $289K | 0.03% |
+5,366
| New | +$289K |
|
311
Incyte
INCY
$16.8B
| $286K | 0.03% |
+3,436
| New | +$286K |
|
312
Cedar Fair
FUN
$2.57B
| $283K | 0.03% |
4,429
-38,273
| -90% | -$2.45M |
|
|
SPLK
313
DELISTED
Splunk Inc
SPLK
| $282K | 0.03% |
2,864
-2,336
| -45% | -$230K |
|
314
Invesco
IVZ
$9.79B
| $276K | 0.03% |
+8,613
| New | +$276K |
|
315
Procter & Gamble
PG
$373B
| $270K | 0.03% |
+3,411
| New | +$270K |
|
316
UnitedHealth
UNH
$281B
| $264K | 0.03% |
1,233
-33,500
| -96% | -$7.17M |
|
317
Erie Indemnity
ERIE
$17.5B
| $262K | 0.03% |
+2,230
| New | +$262K |
|
|
AM
318
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $260K | 0.03% |
10,034
-99,238
| -91% | -$2.57M |
|
319
Vertex Pharmaceuticals
VRTX
$102B
| $257K | 0.03% |
1,576
-36,964
| -96% | -$6.03M |
|
|
PSXP
320
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $256K | 0.03% |
+5,363
| New | +$256K |
|
321
Qiagen
QGEN
$10.2B
| $255K | 0.03% |
+7,456
| New | +$255K |
|
|
BPL
322
DELISTED
Buckeye Partners, L.P.
BPL
| $254K | 0.03% |
+6,803
| New | +$254K |
|
323
Zoetis
ZTS
$68B
| $253K | 0.03% |
+3,033
| New | +$253K |
|
324
Blackstone
BX
$133B
| $252K | 0.03% |
7,891
-5,460
| -41% | -$174K |
|
325
Hancock Whitney
HWC
$5.36B
| $248K | 0.03% |
4,797
-88,000
| -95% | -$4.55M |
|